<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>The Physics Society of Iran</PublisherName>
				<JournalTitle>Iranian Journal of Physics Research</JournalTitle>
				<Issn>1682-6957</Issn>
				<Volume>20</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2021</Year>
					<Month>02</Month>
					<Day>19</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Assessment of the absorbed dose uncertainty of prostate due to tissue swelling and ‎radioactive sources displacement in brachytherapy using 
 Monte Carlo method</ArticleTitle>
<VernacularTitle>Assessment of the absorbed dose uncertainty of prostate due to tissue swelling and ‎radioactive sources displacement in brachytherapy using 
 Monte Carlo method</VernacularTitle>
			<FirstPage>599</FirstPage>
			<LastPage>613</LastPage>
			<ELocationID EIdType="pii">1652</ELocationID>
			
<ELocationID EIdType="doi">10.47176/ijpr.20.4.41043</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Z</FirstName>
					<LastName>Aghaei</LastName>
<Affiliation>Physics Department , Isfahan University of Technology, Isfahan, Iran‎</Affiliation>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Karimian</LastName>
<Affiliation>Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan</Affiliation>
<Identifier Source="ORCID">0000-0003-2543-4772</Identifier>

</Author>
<Author>
					<FirstName>M H</FirstName>
					<LastName>Alamatsaz</LastName>
<Affiliation>Physics Department , Isfahan University of Technology, Isfahan, Iran‎</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>04</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Brachytherapy is a kind of cancer treatment in  which radiation sources are implanted inside or close to the cancerous tissue. ‎The purpose of this research is to calculate the absorbed dose uncertainty of prostate tissue, due to its swelling, ‎displacement of the implanted seed sources and also, to address the effect of these factors simultaneously, in brachytherapy of prostate. ‎In this research, MCNPX2.6 code, the TG-43U1 protocol and ORNL body phantom were used to simulate the brachytherapy ‎of prostate using iodine-125 seed sources. In the first study, 84 sources of iodine with the  shapes of seed and then points  were ‎implanted inside the prostate with the volume of 38.01 cm&lt;sup&gt;3&lt;/sup&gt;. The radiation absorbed dose was found to be 110.59 and ‎‎110.57 Gy, respectively. Considering the 50% prostate inflation after implantation, the radiation absorbed doses of prostate ‎showed a reduction of  more than of 17%. In the second therapeutic plan, by using 76 seed sources of I-125, considering 12% ‎swelling of prostate and applying the  displacement of seed sources in three directions: left–right (1.8mm), front-back (2.1mm) and top–‎down (3.4mm)),  the radiation dose amount of the cancerous tissue was reduced about 21%. So, the results ‎of seed and point sources of brachytherapy were very close to each other. Therefore, in simulation studies, point sources can be used ‎instead of seed sources to  reduce the computational complexity. Also,  this research showed the effects of swelling and ‎displacement of brachytherapy sources on  the amount of  the absorbed dose of prostate and its treatment were‎ noteworthy.</Abstract>
			<OtherAbstract Language="FA">Brachytherapy is a kind of cancer treatment in  which radiation sources are implanted inside or close to the cancerous tissue. ‎The purpose of this research is to calculate the absorbed dose uncertainty of prostate tissue, due to its swelling, ‎displacement of the implanted seed sources and also, to address the effect of these factors simultaneously, in brachytherapy of prostate. ‎In this research, MCNPX2.6 code, the TG-43U1 protocol and ORNL body phantom were used to simulate the brachytherapy ‎of prostate using iodine-125 seed sources. In the first study, 84 sources of iodine with the  shapes of seed and then points  were ‎implanted inside the prostate with the volume of 38.01 cm&lt;sup&gt;3&lt;/sup&gt;. The radiation absorbed dose was found to be 110.59 and ‎‎110.57 Gy, respectively. Considering the 50% prostate inflation after implantation, the radiation absorbed doses of prostate ‎showed a reduction of  more than of 17%. In the second therapeutic plan, by using 76 seed sources of I-125, considering 12% ‎swelling of prostate and applying the  displacement of seed sources in three directions: left–right (1.8mm), front-back (2.1mm) and top–‎down (3.4mm)),  the radiation dose amount of the cancerous tissue was reduced about 21%. So, the results ‎of seed and point sources of brachytherapy were very close to each other. Therefore, in simulation studies, point sources can be used ‎instead of seed sources to  reduce the computational complexity. Also,  this research showed the effects of swelling and ‎displacement of brachytherapy sources on  the amount of  the absorbed dose of prostate and its treatment were‎ noteworthy.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">prostate cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">brachytherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">absorbed dose uncertainty</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Monte Carlo method</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://ijpr.iut.ac.ir/article_1652_207f88018f72237565570f8a9e5ca240.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
